Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human CTNNA1 Protein, N-His

Recombinant Human CTNNA1 Protein, N-His from ProteoGenix; catalogue ARO-P10779; research use only.

SKU:
ABM141220-1
Manufacturer SKU
ARO-P10779
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction to Recombinant Human CTNNA1 Protein

Recombinant Human CTNNA1 Protein is a synthetic version of the human alpha-catenin protein, which is encoded by the CTNNA1 gene. This protein plays a crucial role in cell adhesion and signaling pathways, and its dysfunction has been linked to various diseases, including cancer and developmental disorders. The recombinant form of this protein is produced through genetic engineering techniques, making it a valuable tool for research and therapeutic applications.

Structure of Recombinant Human CTNNA1 Protein

The recombinant form of CTNNA1 protein is a 906 amino acid long polypeptide with a molecular weight of approximately 102 kDa. It consists of three major domains: an N-terminal domain, a central armadillo repeat domain, and a C-terminal domain. The N-terminal domain is responsible for binding to other proteins, while the armadillo repeat domain is involved in protein-protein interactions. The C-terminal domain is responsible for binding to the actin cytoskeleton, which is essential for the protein’s role in cell adhesion.

Recombinant Human CTNNA1 Protein also contains several phosphorylation sites, which play a crucial role in regulating its activity. Phosphorylation of these sites can affect the protein’s binding affinity and stability, making it an essential mechanism for controlling its function.

Activity of Recombinant Human CTNNA1 Protein

Recombinant Human CTNNA1 Protein is a key component of the adherens junction, a specialized structure that mediates cell-cell adhesion. This protein binds to other proteins, such as cadherins and catenins, to form a complex that connects adjacent cells. This interaction is crucial for maintaining the integrity and stability of tissues and organs, as well as for regulating cell signaling pathways.

In addition to its role in cell adhesion, recombinant CTNNA1 protein has been shown to play a role in cell migration, proliferation, and differentiation. It also interacts with other signaling molecules, such as Wnt and TGF-beta, to regulate various cellular processes. Dysregulation of CTNNA1 activity has been linked to cancer progression, as well as developmental disorders, highlighting the importance of this protein in maintaining normal cellular function.

Applications of Recombinant Human CTNNA1 Protein

Recombinant Human CTNNA1 Protein has a wide range of applications in both research and therapeutic settings. In research, this protein is commonly used as a tool to study cell adhesion and signaling pathways. Its recombinant form allows for precise control and manipulation of its activity, making it a valuable tool for understanding the role of CTNNA1 in various cellular processes.

In therapeutic applications, recombinant CTNNA1 protein has shown potential for treating diseases associated with its dysfunction, such as cancer. By targeting the protein’s activity, it may be possible to inhibit tumor growth and metastasis. Additionally, recombinant CTNNA1 protein can be used in tissue engineering to improve cell adhesion and promote tissue regeneration.

Conclusion

Recombinant Human CTNNA1 Protein is a crucial component of cell adhesion and signaling pathways, with its dysfunction linked to various diseases. Its recombinant form allows for precise control and manipulation of its activity, making it a valuable tool for research and therapeutic applications. With its potential for treating diseases and improving tissue engineering, this protein holds promise for future advancements in the field of biotechnology.

ProteoGenix catalogue number ARO-P10779. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 21.97 kDa; Fragment: Gly666-Ser846; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
Renal carcinoma antigen NY-REN-13, Catenin alpha-1, CTNNA1, Alpha E-catenin, Cadherin-associated protein
Host species
E. coli
Source organism
Human
Molecular weight
21.97 kDa
Sequence fragment
Gly666-Ser846
Sequence
GQSARAIMAQLPQEQKAKIAEQVASFQEEKSKLDAEVSKWDDSGNDIIVLAKQMCMIMMEMTDFTRGKGPLKNTSDVISAAKKIAEAGSRMDKLGRTIADHCPDSACKQDLLAYLQRIALYCHQLNICSKVKAEVQNLGGELVVSGVDSAMSLIQAAKNLMNAVVQTVKASYVASTKYQKS
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P10779
UniProt accession
P35221
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
$287.00$230.00